Matinas BioPharma Holdings, Inc. (MTNB) Operating income 2016–2025
Matinas BioPharma Holdings, Inc. (MTNB) annual operating income history from SEC filings — each fiscal year as reported.
-$7.0MFY2025 · since FY2016: -$8.3M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | +71.7% |
| FY2024 | -$24.6M | -3.5% |
| FY2023 | -$23.8M | +3.4% |
| FY2022 | -$24.6M | +0.6% |
| FY2021 | -$24.7M | -2.2% |
| FY2020 | -$24.2M | -27.9% |
| FY2019 | -$18.9M | -29.2% |
| FY2018 | -$14.6M | +11.2% |
| FY2017 | -$16.5M | -99.9% |
| FY2016 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice